$39.35
0.08% yesterday
Nasdaq, Aug 21, 10:00 pm CET
ISIN
US74276L1052
Symbol
PRCT

PROCEPT BioRobotics Target price 2025 - Analyst rating & recommendation

PROCEPT BioRobotics Classifications & Recommendation:

Buy
79%
Hold
21%

PROCEPT BioRobotics Price Target

Target Price $79.05
Price $39.35
Potential
Number of Estimates 12
12 Analysts have issued a price target PROCEPT BioRobotics 2026 . The average PROCEPT BioRobotics target price is $79.05. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 19 analysts: 15 Analysts recommend PROCEPT BioRobotics to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the PROCEPT BioRobotics stock has an average upside potential 2026 of . Most analysts recommend the PROCEPT BioRobotics stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 224.50 331.15
64.84% 47.51%
EBITDA Margin -40.70% -11.96%
47.39% 70.62%
Net Margin -40.72% -25.84%
47.64% 36.54%

15 Analysts have issued a sales forecast PROCEPT BioRobotics 2025 . The average PROCEPT BioRobotics sales estimate is

$331m
Unlock
. This is
20.44% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$351m 27.82%
Unlock
, the lowest is
$316m 14.99%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $225m 64.84%
2025
$331m 47.51%
Unlock
2026
$436m 31.69%
Unlock
2027
$546m 25.21%
Unlock
2028
$614m 12.45%
Unlock
2029
$710m 15.60%
Unlock
2030
$776m 9.31%
Unlock

12 Analysts have issued an PROCEPT BioRobotics EBITDA forecast 2025. The average PROCEPT BioRobotics EBITDA estimate is

$-39.6m
Unlock
. This is
53.90% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-36.0m 58.13%
Unlock
, the lowest is
$-63.7m 25.89%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-91.4m 13.27%
2025
$-39.6m 56.65%
Unlock
2026
$-3.3m 91.74%
Unlock
2027
$37.3m 1,239.27%
Unlock

EBITDA Margin

2024 -40.70% 47.39%
2025
-11.96% 70.62%
Unlock
2026
-0.75% 93.73%
Unlock
2027
6.82% 1,009.33%
Unlock

15 PROCEPT BioRobotics Analysts have issued a net profit forecast 2025. The average PROCEPT BioRobotics net profit estimate is

$-85.6m
Unlock
. This is
1.68% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-80.5m 4.29%
Unlock
, the lowest is
$-87.2m 3.57%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-91.4m 13.68%
2025
$-85.6m 6.40%
Unlock
2026
$-57.9m 32.35%
Unlock
2027
$-26.3m 54.51%
Unlock
2028
$-13.6m 48.31%
Unlock
2029
$11.3m 183.32%
Unlock
2030
$35.2m 209.96%
Unlock

Net Margin

2024 -40.72% 47.64%
2025
-25.84% 36.54%
Unlock
2026
-13.27% 48.65%
Unlock
2027
-4.82% 63.68%
Unlock
2028
-2.22% 53.94%
Unlock
2029
1.60% 172.07%
Unlock
2030
4.53% 183.13%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.75 -1.54
21.88% 12.00%
P/E negative
EV/Sales 5.86

15 Analysts have issued a PROCEPT BioRobotics forecast for earnings per share. The average PROCEPT BioRobotics EPS is

$-1.54
Unlock
. This is
1.99% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.45 3.97%
Unlock
, the lowest is
$-1.57 3.97%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.75 21.88%
2025
$-1.54 12.00%
Unlock
2026
$-1.04 32.47%
Unlock
2027
$-0.47 54.81%
Unlock
2028
$-0.24 48.94%
Unlock
2029
$0.20 183.33%
Unlock
2030
$0.63 215.00%
Unlock

P/E ratio

Current -26.08 19.36%
2025
-25.58 1.92%
Unlock
2026
-37.81 47.81%
Unlock
2027
-83.13 119.86%
Unlock
2028
-160.87 93.52%
Unlock
2029
193.04 220.00%
Unlock
2030
62.27 67.74%
Unlock

Based on analysts' sales estimates for 2025, the PROCEPT BioRobotics stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.05 61.05%
2025
5.86 16.91%
Unlock
2026
4.45 24.06%
Unlock
2027
3.55 20.14%
Unlock
2028
3.16 11.07%
Unlock
2029
2.73 13.49%
Unlock
2030
2.50 8.52%
Unlock

P/S ratio

Current 7.97 58.11%
2025
6.62 16.97%
Unlock
2026
5.02 24.06%
Unlock
2027
4.01 20.14%
Unlock
2028
3.57 11.07%
Unlock
2029
3.09 13.49%
Unlock
2030
2.82 8.52%
Unlock

Current PROCEPT BioRobotics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
Locked
Locked Aug 07 2025
Wells Fargo
Locked
Locked
Locked Aug 07 2025
Morgan Stanley
Locked
Locked
Locked Jul 15 2025
Oppenheimer
Locked
Locked
Locked Jul 07 2025
B of A Securities
Locked
Locked
Locked Apr 25 2025
Truist Securities
Locked
Locked
Locked Apr 11 2025
Morgan Stanley
Locked
Locked
Locked Feb 26 2025
Analyst Rating Date
Locked
Piper Sandler:
Locked
Locked
Aug 07 2025
Locked
Wells Fargo:
Locked
Locked
Aug 07 2025
Locked
Morgan Stanley:
Locked
Locked
Jul 15 2025
Locked
Oppenheimer:
Locked
Locked
Jul 07 2025
Locked
B of A Securities:
Locked
Locked
Apr 25 2025
Locked
Truist Securities:
Locked
Locked
Apr 11 2025
Locked
Morgan Stanley:
Locked
Locked
Feb 26 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today